Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

HKEX:2630 stock price forecast

How will HKEX:2630 stock perform in 2026 and 2030?

This page primarily displays the projected price range for HKEX:2630 stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of HKEX:2630, the development trends of Vigonvita Life Sciences Co., Ltd. Class H, and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for HKEX:2630. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Vigonvita Life Sciences Co., Ltd. Class H's financial performance and industry trends to provide short-term price predictions for HKEX:2630 stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year HKEX:2630 stock price forecast

Price target:
215.82 HKD
+79.85%
Based on 1-year price forecasts from 85 analysts, the highest estimate is 326.53 HKD, while the lowest estimate is 88.24 HKD.

Analyst rating for HKEX:2630

Based on ratings from 67 analysts over the past three months, the overall consensus is Hold.

Strong buy
17
Buy
23
Hold
15
Sell
0
Strong sell
12

FAQ

How has HKEX:2630's EPS performed recently?

HKEX:2630's EPS is projected to reach -- HKD next quarter. Explore more Vigonvita Life Sciences Co., Ltd. Class H financial data and stay up to date on the company's latest developments on the HKEX:2630 stock details page.

What is the revenue forecast for HKEX:2630 next quarter?

Vigonvita Life Sciences Co., Ltd. Class H's revenue is projected to reach -- HKD in the next quarter. You can view Vigonvita Life Sciences Co., Ltd. Class H's revenue and earnings on the HKEX:2630 stock details page.

What is the price target for HKEX:2630?

Based on analyst estimates, the most likely target price for HKEX:2630 over the next 12 months is 215.82 HKD, with a projected high of 326.53 HKD and a projected low of 88.24 HKD. To track whether this target is reached within the next year, you can view the HKEX:2630 stock price chart on the HKEX:2630 stock details page to check the current HKEX:2630 stock price, or follow the latest developments related to HKEX:2630 on the HKEX:2630 Stock News page.

What is the analyst rating for HKEX:2630?

We collected ratings from 67 analysts who have evaluated HKEX:2630 stock over the past three months. Most analysts maintain a Hold outlook, and after aggregating all opinions, the overall consensus rating is Hold. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of HKEX:2630 stock in 2030?

Based on price forecasts and analyses of Vigonvita Life Sciences Co., Ltd. Class H from Wall Street analysts and major investment banks, HKEX:2630 is projected to trade between 240.00 HKD and 1200.00 HKD in 2030.

HKEX:2630 stock price change

On the last trading day, HKEX:2630 stock closed at 120.00 HKD, with a price change of 9.09% for the day.

Trade stock futuresHKEX:2630 stock details

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
HKEX/
HKEX:2630 stock price forecast